Literature DB >> 6826254

Lectins as probes for identification of tumor-associated antigens on urothelial and colonic carcinoma cell lines.

S Paulie, Y Hansson, M L Lundblad, P Perlmann.   

Abstract

In the search for tumor-associated antigens, seven lectins were used to investigate the cellular distribution of membrane-associated glycoproteins on a panel of human cells derived from tumor or normal tissues. Surface labelled lysates of the different cells were precipitated with the lectins and the precipitates were separated on SDS-PAGE. Comparison of the autoradiographic patterns revealed that a La-reactive 115K glycopeptide (gp 115) was present on transitional-cell carcinoma cells of the urinary bladder, on two spontaneously transformed urothelial cell lines and on a melanoma cell line. Gp 115 was absent from a non-transformed urothelial cell line, a squamous bladder carcinoma line and five unrelated cell lines of miscellaneous tissue origin. When precipitation was performed with a rabbit antiserum raised against the La-reactive components of a TCC cell line the same distribution of gp 115 was observed. From Helix pomatia hemagglutinin (HP) precipitates a 150K glycopolypeptide co-migrating with a previously described HP-reactive differentiation antigen associated with human T cells was present on one of the urothelial cell lines and on a colon carcinoma cell line. When different extracts depleted of ConA binding glycopeptides were compared, a group of three antigens (32K, 35K and 40K) were identified in the extracts of the colon carcinoma cell line, HT29. These antigens were shared by two other colon carcinoma cell lines but were absent from the unrelated cells of our panel. Furthermore, an extensively absorbed rabbit anti-HT29 serum specifically precipitated one of these antigens (35K) from the three colon cell lines.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6826254     DOI: 10.1002/ijc.2910310308

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.

Authors:  C D Hurst; D C Tomlinson; S V Williams; F M Platt; M A Knowles
Journal:  Oncogene       Date:  2007-11-26       Impact factor: 9.867

2.  Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. II. Identification of the cellular target structures by immunoprecipitation and SDS-PAGE analysis.

Authors:  S Paulie; H Koho; H Ben-Aissa; Y Hansson; M L Lundblad; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence.

Authors:  H Koho; S Paulie; H Ben-Aissa; I Jónsdóttir; Y Hansson; M L Lundblad; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  Humoral and cellular immune reactions against tumor cells in patients with urinary bladder carcinoma. Correlation between direct and antibody-dependent cell-mediated cytotoxicity.

Authors:  Y Hansson; S Paulie; A Larsson; M L Lundblad; P Perlmann; I Näslund
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

5.  Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder.

Authors:  M A Knowles
Journal:  Urol Res       Date:  1992

6.  Radioiodinated peanut lectin: clinical use as a tumour-imaging agent and potential use in assessing renal-tubular function.

Authors:  E A Abdi; V J Kamitomo; T A McPherson; Z Catz; G Boniface; B M Longenecker; A A Noujaim
Journal:  Eur J Nucl Med       Date:  1986

7.  Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder.

Authors:  H Ben-Aissa; S Paulie; H Koho; P Biberfeld; Y Hansson; M L Lundblad; H Gustafson; I Jonsdottir; P Perlmann
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

8.  Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma.

Authors:  L M Coombs; D A Pigott; M E Eydmann; A J Proctor; M A Knowles
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

9.  Identification of glycoproteins expressing tumour-associated PNA-binding sites in colorectal carcinomas by SDS-GEL electrophoresis and PNA-labelling.

Authors:  I Kellokumpu; S Kellokumpu; L C Andersson
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.